Premier Biomedical, Inc. (BIEI) Featured in Wall Street Transcript Interview, Provides Insight to Revolutionary Medical Treatment R&D
Premier Biomedical president and CEO William Hartman was recently interviewed by The Wall Street Transcript (TWST), an independent investment publication, to discuss Premier’s medical treatment research and development. In the interview, Hartman details the company’s technology and unique approach to battle cancer. Utilizing the Felder Doctrine™ developed by company co-founder Dr. Mitchell Felder, Premier physically removes the pathophysiologic basis of a disease by processing the body fluids, such as blood for blood-borne diseases and cerebral spinal fluid for neurologic-based diseases. With this method, Premier has successfully eradicated a cancer tumor in a test tube by eliminating the molecular compounds integral…